Immunomodulatory Effects in a Phase II Study of Lenalidomide Combined with Cetuximab in Refractory KRAS-Mutant Metastatic Colorectal Cancer Patients

Overview of attention for article published in PLOS ONE, November 2013

Altmetric Badge

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 28 Dimensions

Readers on

mendeley: 53 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

Methods for treating multiple myeloma and the use of companion biomarkers for 4-(4-(4-(((2…

Grant US-11726080-B2

United States of America

Methods for treating multiple myeloma and the use of companion biomarkers for 4-(4-(4-(((2…

Grant US-10969381-B2

United States of America